Mark Kalinich

1.4k total citations
15 papers, 303 citations indexed

About

Mark Kalinich is a scholar working on Psychiatry and Mental health, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mark Kalinich has authored 15 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 6 papers in Oncology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mark Kalinich's work include Electroconvulsive Therapy Studies (7 papers), Bipolar Disorder and Treatment (5 papers) and Takotsubo Cardiomyopathy and Associated Phenomena (4 papers). Mark Kalinich is often cited by papers focused on Electroconvulsive Therapy Studies (7 papers), Bipolar Disorder and Treatment (5 papers) and Takotsubo Cardiomyopathy and Associated Phenomena (4 papers). Mark Kalinich collaborates with scholars based in United States, United Kingdom and France. Mark Kalinich's co-authors include James Luccarelli, Scott R. Beach, Vartan Pahalyants, Feicheng Wang, Gregory L. Fricchione, Shannon Wongvibulsin, Yevgeniy R. Semenov, William S. Murphy, Kerry L. Reynolds and Kun‐Hsing Yu and has published in prestigious journals such as Gastroenterology, PLoS ONE and Journal of Investigative Dermatology.

In The Last Decade

Mark Kalinich

14 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Kalinich United States 8 171 76 67 57 57 15 303
Anna Linder Sweden 10 57 0.3× 53 0.7× 23 0.3× 69 1.2× 63 1.1× 19 214
Shalaka Joshi India 10 101 0.6× 80 1.1× 33 0.5× 74 1.3× 23 0.4× 43 305
Laura Scaltriti Italy 8 225 1.3× 60 0.8× 7 0.1× 79 1.4× 77 1.4× 10 456
Samuel Levy United States 5 68 0.4× 84 1.1× 22 0.3× 95 1.7× 21 0.4× 16 181
Suiyi Wu China 11 79 0.5× 80 1.1× 8 0.1× 124 2.2× 31 0.5× 16 294
Liselot Valkenburg‐van Iersel Netherlands 8 122 0.7× 17 0.2× 37 0.6× 62 1.1× 69 1.2× 21 225
Samuel Q. Li United States 7 57 0.3× 37 0.5× 9 0.1× 117 2.1× 57 1.0× 14 265
Ghasem Janbabaei Iran 9 132 0.8× 28 0.4× 17 0.3× 41 0.7× 37 0.6× 27 281
Minguang Zhang China 12 54 0.3× 45 0.6× 60 0.9× 79 1.4× 61 1.1× 13 347

Countries citing papers authored by Mark Kalinich

Since Specialization
Citations

This map shows the geographic impact of Mark Kalinich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kalinich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kalinich more than expected).

Fields of papers citing papers by Mark Kalinich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Kalinich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kalinich. The network helps show where Mark Kalinich may publish in the future.

Co-authorship network of co-authors of Mark Kalinich

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Kalinich. A scholar is included among the top collaborators of Mark Kalinich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Kalinich. Mark Kalinich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Luccarelli, James, Mark Kalinich, Jonathan Rogers, et al.. (2025). Emergency Department Presentations for Catatonia: A 2019–2021 National Emergency Department Sample Study. Journal of the Academy of Consultation-Liaison Psychiatry. 66(5). 380–388.
2.
Luccarelli, James, Mark Kalinich, Jo Ellen Wilson, et al.. (2025). The Catatonia Quick Screen ( CQS ): A Rapid Screening Tool for Catatonia in Adult and Pediatric Populations. Acta Psychiatrica Scandinavica. 152(5). 341–349. 2 indexed citations
3.
Luccarelli, James, Joshua R. Smith, Mark Kalinich, Ali Amad, & Jonathan Rogers. (2025). The Population-Based Incidence and Prevalence of Catatonia. Journal of Neuropsychiatry. 37(2). 160–162. 4 indexed citations
4.
Luccarelli, James, Mark Kalinich, Gregory L. Fricchione, et al.. (2024). Diagnostic and demographic factors of pediatric and adult catatonia hospitalizations: A 2016–2020 National Inpatient Sample Study. Acta Psychiatrica Scandinavica. 150(4). 234–244. 10 indexed citations
5.
Luccarelli, James, Mark Kalinich, Carlos Fernandez-Robles, Gregory L. Fricchione, & Scott R. Beach. (2022). The Incidence of Catatonia Diagnosis Among Pediatric Patients Discharged From General Hospitals in the United States: A Kids' Inpatient Database Study. Frontiers in Psychiatry. 13. 878173–878173. 25 indexed citations
6.
Luccarelli, James, Mark Kalinich, Thomas H. McCoy, et al.. (2022). The occurrence of catatonia diagnosis in acute care hospitals in the United States: A national inpatient sample analysis. General Hospital Psychiatry. 77. 141–146. 19 indexed citations
7.
Luccarelli, James, Mark Kalinich, Thomas H. McCoy, et al.. (2022). Co-Occurring Catatonia and COVID-19 Diagnoses Among Hospitalized Individuals in 2020: A National Inpatient Sample Analysis. Journal of the Academy of Consultation-Liaison Psychiatry. 64(3). 209–217. 4 indexed citations
8.
Nguyen, Thao, Yiling Liu, Emma K. Accorsi, et al.. (2021). Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States. PLoS ONE. 16(6). e0243676–e0243676. 11 indexed citations
9.
Kalinich, Mark, S Ebrahim, Ryan Hays, et al.. (2021). Applying machine learning to smartphone based cognitive and sleep assessments in schizophrenia. Schizophrenia Research Cognition. 27. 100216–100216. 5 indexed citations
10.
Wongvibulsin, Shannon, Vartan Pahalyants, Mark Kalinich, et al.. (2021). Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis. Journal of the American Academy of Dermatology. 86(3). 563–572. 57 indexed citations
11.
Kalinich, Mark, William S. Murphy, Shannon Wongvibulsin, et al.. (2021). Prediction of severe immune-related adverse events requiring hospital admission in patients on immune checkpoint inhibitors: study of a population level insurance claims database from the USA. Journal for ImmunoTherapy of Cancer. 9(3). e001935–e001935. 57 indexed citations
12.
Wongvibulsin, Shannon, Vartan Pahalyants, Mark Kalinich, et al.. (2021). 379 Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune checkpoint inhibitors: A United States population-level analysis. Journal of Investigative Dermatology. 141(5). S66–S66. 3 indexed citations
13.
Kalinich, Mark, Tanya T. Kwan, Mehmet Toner, Daniel A. Haber, & Shyamala Maheswaran. (2019). Quantitative Analysis of Circulating Tumor Cells Using RNA-Based Digital Scoring. Recent results in cancer research. 215. 77–88. 2 indexed citations
14.
Kwan, Tanya T., Aditya Bardia, Laura M. Spring, et al.. (2018). A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer. Cancer Discovery. 8(10). 1286–1299. 78 indexed citations
15.
Bhan, Irun, Lipika Goyal, Julia Philipp, et al.. (2018). Detection and Analysis of Circulating Epithelial Cells in Liquid Biopsies From Patients With Liver Disease. Gastroenterology. 155(6). 2016–2018.e11. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026